YBX1 and cancer: Elevated expression of HOXC-AS3/YBX1/HOXC8 occurs in NSCLC cells, and inhibition of their expression significantly suppresses cancer cell proliferation, migration and invasion, resulting in attenuated tumour growth and metastasis in vivo.